司太立(603520.SH):目前仙居廠區處於停產自查狀態
格隆匯 8 月 7日丨司太立(603520.SH)公佈,公司股票於2020年8月5日、8月6日及8月7日連續三個交易日內收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動。
公司碘海醇粗品生產車間於2020年7月27日晚發生爆炸事故,事故相關調查結果尚未作出,目前公司仙居廠區處於停產自查狀態,預計停產時間不超過3個月。公司將根據事故調查進展及時履行信息披露義務,敬請投資者注意投資風險。
目前除浙江仙居廠區處於停產自查狀態以外,公司位於浙江臨海的台州海神製藥有限公司、江西樟樹的江西司太立製藥有限公司及上海金山的上海司太立製藥有限公司均處於正常經營狀態。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.